FORA Capital’s Amgen AMGN Stock Holding History

FORA Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,256	Closed	-$442K	–	358
2026 Q1	$442K	Sell	1,256 -2,981	-70%	-$1.06M	0.03%	319
2025 Q4	$1.39M	Sell	4,237 -154	-4%	-$48.9K	0.17%	149
2025 Q3	$1.24M	Buy	+4,391	New	+$1.27M	0.22%	126
2025 Q2	–	Sell	-730	Closed	-$227K	–	497
2025 Q1	$227K	Sell	730 -11,075	-94%	-$3.27M	0.02%	432
2024 Q4	$3.08M	Buy	+11,805	New	+$3.5M	0.35%	87
2023 Q3	–	Sell	-34,371	Closed	-$7.63M	–	449
2023 Q2	$7.63M	Buy	+34,371	New	+$7.98M	1.08%	16
2023 Q1	–	Sell	-10,906	Closed	-$2.86M	–	509
2022 Q4	$2.86M	Buy	+10,906	New	+$2.92M	0.46%	54
2022 Q1	–	Sell	-8,722	Closed	-$1.96M	–	501
2021 Q4	$1.96M	Buy	8,722 +932	+12%	+$197K	0.76%	25
2021 Q3	$1.66M	Sell	7,790 -1,032	-12%	-$238K	0.42%	74
2021 Q2	$2.15M	Buy	8,822 +341	+4%	+$83.9K	0.4%	61
2021 Q1	$2.11M	Buy	+8,481	New	+$2.02M	0.69%	28
2020 Q1	–	Sell	-10,575	Closed	-$2.55M	–	1018
2019 Q4	$2.55M	Buy	+10,575	New	+$2.33M	0.26%	99

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FORA Capital's AMGN Position: Q2 2026 in Review

FORA Capital sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,256 shares — an estimated $442K sold.

FORA Capital first reported a position in AMGN in Q4 2019 and held it in 12 quarters. The position peaked at $7.63M in Q2 2023. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

FORA Capital reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
FORA Capital sold 1,256 Amgen shares in Q2 2026, an estimated $442K.
FORA Capital first reported a position in Amgen in Q4 2019 and held it in 12 quarters.
FORA Capital's Amgen position peaked at $7.63M in Q2 2023.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.